Business Context and Reporting Period
This Form 6-K, dated November 21, 2014, reports on the successful conclusion of the initial acceptance period for a share-for-share exchange offer between UBS Group AG and UBS AG. The filing announces that the offer has become unconditional and provides preliminary interim results regarding the tender of UBS AG shares.
Key Financial Metrics and Transaction Data
The filing focuses on transaction volumes rather than traditional financial performance metrics (revenue, profit, cash flow). Key data points include:
- Total Issued UBS AG Shares: 3,844,560,913
- Total Tendered Shares: 3,475,356,441
- Overall Acceptance Ratio: 90.40% of all issued shares
- Shareholder Acceptance Ratio: 90.18% (excluding treasury shares)
- Treasury Shares Tendered: 90,815,594
- Shares Tendered by Shareholders: 3,384,540,847
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes and Transaction Status
As of the close of the initial acceptance period on November 20, 2014, all offer conditions have been satisfied or waived. Consequently, UBS Group AG has declared the public exchange offer unconditional. The acceptance rate of 90.40% exceeds the threshold required to ensure that remaining UBS AG shares will be squeezed out, though this process may take an extended period. UBS Group AG will own 90.40% of the share capital and voting rights of UBS AG upon settlement.
Outlook, Management Commentary, and Risks
Settlement and Trading: First settlement is expected on or around November 28, 2014. Trading in UBS Group AG shares (Ticker: UBSG on SIX, UBS on NYSE) is expected to commence on that date. Remaining non-tendered UBS AG shares will trade under ticker "OUBS" on the NYSE starting November 24, 2014, and will remain tradable on the SIX until delisting.
Additional Acceptance Period: A subsequent offer period is expected to run from November 26 to December 10, 2014, allowing holders of remaining shares to tender. No withdrawal rights will apply during this period.
Risks and Contingencies: The filing includes a cautionary statement regarding forward-looking statements. Key risks cited include:
- Execution of strategic plans, including efficiency initiatives and reduction of Basel III risk-weighted assets.
- Market developments, including liquidity, credit spreads, and interest rates.
- Changes in capital, funding, and regulatory requirements in Switzerland, the US, and the UK.
- Regulatory approval of capital requirement reductions by FINMA.
- Legal entity restructuring and resolvability requirements.
- Operational failures, litigation, and reputational risks.
Investor Verification Checklist
- Verify the definitive interim results of the exchange offer, expected to be published on November 26, 2014.
- Confirm the commencement of "regular way" trading for UBS Group AG on the NYSE and SIX on November 28, 2014.
- Monitor the timeline for the delisting of UBS AG shares from the SIX Swiss Exchange and NYSE.
- Review the EU AAP Prospectus for details on the public offering during the additional acceptance period.
- Assess the impact of the squeeze-out process on the liquidity and valuation of any remaining non-tendered UBS AG shares.